Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Genetic Signature Discovered in Plaque

August 5, 2011 6:23 am | News | Comments

Differences in artery plaque in people who had stroke and people who didn’t could allow researchers to target treatments to plaques that are most likely to rupture.


DePuy Spending $27M on New Equipment

August 5, 2011 6:20 am | News | Comments

DePuy Orthopaedics, a Johnson & Johnson subsidiary that makes hip replacements and other artificial joint products, is planning to spend $27 million on manufacturing and research equipment.


Aeterna Completes Phase 3 Trial

August 5, 2011 6:13 am | News | Comments

Aeterna Zentaris Inc. announced completion of its Phase 3 study with AEZS-130 as the first oral diagnostic test for adult growth hormone deficiency. The company is currently preparing for a pre-New Drug Application meeting with the FDA.


FDA Approves Scorpion Antivenin

August 5, 2011 6:00 am | News | Comments

The U.S. Food and Drug Administration approved Anascorp, the first specific treatment for a scorpion sting by Centruroides scorpions in the United States. Untreated stings can be fatal.


Amylin, Takeda Kill Obesity Treatment

August 5, 2011 5:44 am | News | Comments

Amylin Pharmaceuticals Inc. and Takeda Pharmaceutical Co. Ltd. said that they are discontinuing development of pramlintide/metreleptin, a combination therapy to treat obesity.


Prestige Income Up Over 50%

August 5, 2011 5:40 am | News | Comments

Prestige Brands Holdings Inc. said that net income in the most recent quarter soared 54 percent as strong sales of over-the-counter medicines made up for a decline elsewhere.


Valeant Earnings Jump, Wall Street Unimpressed

August 5, 2011 5:38 am | News | Comments

Valeant Pharmaceuticals inched said that second-quarter earnings grew 66 percent, as revenue climbed after its purchase last September by Biovail Corp. Valeant also raised its outlook somewhat, but still failed to meet Wall Street expectations.


Aggressive Drug Therapy Leading to Superbugs

August 4, 2011 10:17 am | News | Comments

New research raises troubling concerns about the use of aggressive drug therapies to treat a wide range of diseases such as MRSA, C. difficile, malaria, and even cancer.


Dr. Reddy's Launches Generic Arixtra

August 4, 2011 10:11 am | News | Comments

Dr Reddy’s Laboratories has launched their generic fondaparinux sodium for injection in the United States. The launch follows the approval by the US Food and Drug Administration of the Abbreviated New Drug Application in July.


Amarantus and Generex in Diabetes Collaboration

August 4, 2011 10:02 am | News | Comments

Amarantus BioSciences, a biotechnology company developing a therapeutic protein known as MANF, and Generex Biotechnology Corporation, a biotechnology company developing Generex Oral-lyn, are releasing the details of their third diabetes research collaboration.


New Drug Targets Cancer's Sugar Supply

August 4, 2011 9:51 am | News | Comments

Researchers have identified a compound that attacks the Achilles’ heel of certain cancer cells—depriving them of their energy source, the sugar glucose—and does so with minimal side effects.


Virtual Microscopy Slide Scanning System

August 4, 2011 6:28 am | Product Releases | Comments

The VS120 virtual microscopy slide scanning system from Olympus scans faster than ever before, offers image deconvolution/deblurring for ultra-sharp images and provides important fluorescence imaging capabilities.


CCD Imaging System

August 4, 2011 6:22 am | Product Releases | Comments

Syngene released results from a head-to-head study demonstrating that the G:BOX Chemi IR6 can produce images of IR labeled Western blots up to 10 times faster than laser based scanning.


New Verification Services Available from ATCC

August 4, 2011 6:07 am | News | Comments

American Type Culture Collection has launched an STR Profiling Service for human cell line authentication. ATCC has over 20 years experience performing short STR profiling, giving investigators the surest solution to verify the identity of their human cell lines.


Sales Boost Allergan Income

August 4, 2011 5:59 am | News | Comments

Botox maker Allergan Inc.'s second-quarter net income rose 3 percent, on sales growth for specialty drugs and medical devices. The company also raised its earnings and net sales expectations for 2011.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.